Cancer Management and Research
Volume 11, 2019 - Issue
Original Research
Elevated levels of pre-treatment lactate dehydrogenase are an unfavorable predictor factor in patients with EML4-ALK rearrangement non-small cell lung cancer treated with crizotinib
Hongge Liang1 Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China
https://orcid.org/0000-0001-8954-2065
https://orcid.org/0000-0001-8954-2065, , Yan Xu1 Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, People’s Republic of Chinahttps://orcid.org/0000-0002-2832-2664
https://orcid.org/0000-0002-2832-2664, , Minjiang Chen1 Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, People’s Republic of Chinahttps://orcid.org/0000-0002-4040-6115
https://orcid.org/0000-0002-4040-6115, , , & show all